Generex Biotechnology Corp Watch

from S-1 11 pages Neither This Security Nor the Securities as to Which This Security May Be Exercised Have Been Registered With the Securities and Exchange Commission or the Securities Commission of Any State in Reliance Upon an Exemption From Registration Under the Securities Act of 1933, as Amended (The “Securities Act”), And, Accordingly, May Not Be Offered or Sold Except Pursuant to an Effective Registration Statement Under the Securities Act or Pursuant to an Available Exemption From, or in a Transaction Not Subject To, the Registration Requirements of the Securities Act and in Accordance With Applicable State Securities Laws as Evidenced by a Legal Opinion of Counsel to the Transferor to Such Effect, the Substance of Which Shall Be Reasonably Acceptable to the Company. This Security and the Securities Issuable Upon Exercise of This Security May Be Pledged in Connection With a Bona Fide Margin Account or Other Loan Secured by Such Securities. Common Stock Purchase Warrant Generex Biotechnology Corporation Warrant Shares: 62,857 Date of Issuance: August 14, 2019